![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: John Toon
jtoon@gatech.edu
404-894-6986
Georgia Institute of Technology Research News
Caption: Georgia Tech/Emory biomedical engineering assistant professor Manu Platt (standing) and graduate student Keon-Young Park examine gels that display the activity levels of cathepsins -- protein-degrading enzymes known to accelerate atherosclerosis, osteoporosis and cancer. In a new study, the researchers developed a technique to predict from a blood sample the amount of cathepsins a specific person would produce.
Credit: Georgia Tech Photo: Gary Meek
Usage Restrictions: None
Related news release: Researchers use blood testing to predict level of enzymes that facilitate disease progression
|